HCPLive

Top Medical News Today

Cardioverter Study DANISH Challenges Heart Failure Guidelines
Implantable cardioverter-defibrillators are not for all heart failure patients, the DANISH study found.
In the ongoing search for subclinical markers of heart disease, Taiwan researchers found that the diameter of the aortic root is a useful predictor.
Heart failure patients with reduced ejection fraction do better with cardiac interventions, particularly CABG, a meta-analysis of 20 studies found.
Think you should hang up those running shoes after 65? Think again, Finish researchers report. Older people who spent at least 3 hours weekly working up a sweat and high heart rate had fewer heart events.
Pope Francis plans to appear at the ESC Congress 2016 to endorse the group's healthy lifestyle campaign.
Poushali Mukherjea, PhD, Executive Director, Global Medical Affairs, Bristol-Myers Squibb, noted some key takeaways from her team’s 19 abstracted slated to be presented at the European Society of Cardiology Congress 2016 (ESC).
Statins should not be physicians' first option in treating all patients at high risk of cardiovascular disease, according to new European treatment guidelines.
Sonal Bhatia, MD, Vice President, Global Eliquis Medical Lead, Pfizer, highlighted the significance of the consistency in data over the last five years, in relation to the five-year-anniversary of her team's Aristotle study at the European Society of Cardiology 2016 (ESC).
An international team looked at oral anticoagulants and decided dabigatran is the best for stroke prevention in non-valvular atrial fibrillation.

Most Popular

@MDMagazine

$vacMongoViewPlus$ $vAR$